On Wednesday, Following Stocks were among the “Top Losers” of U.S. Stock Market: GOL Linhas Aéreas Inteligentes, (NYSE:GOL), United Continental Holdings, (NYSE:UAL), Cerus Corporation, (NASDAQ:CERS), TrueCar, (NASDAQ:TRUE)
GOL Linhas Aéreas Inteligentes, (NYSE:GOL), with shares declined -4.94%, closed at $2.31, hitting new 52-week low of $2.31.
United Continental Holdings, (NYSE:UAL), with shares dropped -4.82%, settled at $64.01.
Cerus Corporation, (NASDAQ:CERS), with shares dipped -4.80%, and closed at $3.97.
TrueCar, (NASDAQ:TRUE), plummeted -4.76%, and closed at $17.
Latest NEWS regarding these Stocks are depicted underneath:
GOL Linhas Aéreas Inteligentes S.A. (NYSE:GOL)
GOL Linhas Aéreas Inteligentes S.A. (GOL), declared its 4Q14 Results.
Highlights:
Operating revenue (EBIT) of R$505 million in 2014, with an operating margin of 5.0%, up 89.8% contrast to R$266 million recorded in 2013. In 4Q14, EBIT came to R$170.7 million, a 4.8% improvement over 4Q13, with a margin of 6.3%, up by 0.3 percentage point.
Net proceed reached R$10 billion in the year, 12.4% more than in 2013, being R$9.0 billion inpassenger proceed and R$1 billion in ancillary proceeds, increasing its share of total proceed from 9.3%, in 2013, to 10.1%. Internationalproceed amounted to R$1.2 billion, equivalent to 12% of the total. In 4Q14, net proceed totaled R$2.7 billion, in line with 4Q13.
Gol Linhas Aéreas Inteligentes S.A. provides regular and non-regular air transportation services for passengers, cargoes, and mailbags in Brazil and internationally. It operates in two segments, Flight Transportation and Smiles Loyalty Program.
United Continental Holdings, Inc. (NYSE:UAL)
Formerly on March 9, United Continental Holdings, Inc. (UAL), stated February 2015 operational results.
UAL’s February 2015 merged traffic (proceed passenger miles) was flat and merged capacity (accessible seat miles) reduced 0.4 percent as compared to February 2014. UAL’s February 2015 merged load factor raised 0.3 points contrast to February 2014.
United Continental Holdings, Inc., together with its auxiliaries, provides air transportation services in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. It transports people and cargo through its mainline operations, which use jet aircraft with at least 118 seats, and its regional operations. As of December 31, 2014, the corporation operated a fleet of 1,257 aircraft. It also sells fuel; and provides maintenance, ground handling, and catering services for third parties.
Cerus Corporation (NASDAQ:CERS)
Formerly on March 16, Cerus Corporation (CERS), declared that the first patient has been enrolled in its TReatment UsE (TRUE) study to make the INTERCEPT Blood System for platelets accessible to regions in the United States with outbreaks of chikungunya and dengue virus under an Expanded Access Investigational Device Exemption (IDE). The American Red Cross is producing INTERCEPT platelet components for the study, which is being conducted in Puerto Rico.
Dengue viruses are endemic to the Caribbean region, and local transmission of chikungunya virus was first confirmed there in early December 2013. Both viruses are spread by species of mosquitos endemic to tropical climates, in addition to regions such as the Southeastern US. Concerns regarding possible transfusion transmission of chikungunya during the major epidemic in the Caribbean region throughout 2014 resulted in the issuance of a Puerto Rico Department of Health administrative order requiring that all blood donations be quarantined for 72 hours pending follow-up on donor history for acute infectious symptoms. As an alternative safety measure, the American Red Cross halted local platelet collections and began supplying Puerto Rico with blood components imported from the continental US.
Cerus Corporation operates as a biomedical products corporation focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication and designed to target and inactivate blood-borne pathogens, counting viruses, bacteria, and parasites, in addition to potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products.
TrueCar, Inc. (NASDAQ:TRUE)
TrueCar, Inc. (TRUE)’s administration took part in Bank of America Merrill Lynch’s 2015 New York Auto Summit held on Wednesday, April 1, 2015, at the JW Marriott Essex House in New York City.
TrueCar, Inc. operates as an Internet-based information, technology, and communication services corporation. The corporation operates its platform on the TrueCar Website and TrueCar mobile applications. It also customizes and operates its platform for its affinity group marketing partners, counting financial institutions, membership-based organizations, and employee buying programs for large enterprises.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
